For Debate: Enzymes as Targets for Autoantibodies in Human Autoimmune disease: Relevance to Pathogenesis?

References

• Weetman A P, McGregor AM. Autoimmune thyroid disease: developments in our undemanding. Endocrine Revs 1984; 5: 309–355
   PubMed Web of Science ®Google Scholar
• Roit IM. Essential Immunology. Blackwell. 1988
   Google Scholar
• Banga J P, Pryce G, Hammond L, Roitt I. Structural features of the autoantigens involved in thyroid autoimmunity: the thyroid microsomal/microvillar antigen. Mol Immunol 1985; 22: 629–642
   PubMed Web of Science ®Google Scholar
• Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid disease. FEBS Letrs 1985; 190: 147–1524
   PubMed Web of Science ®Google Scholar
• Portmann L, Hamada N, Heinrich G, De Groot LJ. Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with antimicrosomal antibody. J Clin Endocrinol Metab 1985; 61: 1001–1003
   PubMed Web of Science ®Google Scholar
• Van de Water J, Gershwin E, Leung P, Ansari A, Coppel RL. The autoepitope of the 74-kD mictochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988; 167: 1791–1799
   PubMed Web of Science ®Google Scholar
• Van de Water J, Fregeau 0, Davis P, Ansari A, Danner D, Leung P, Coppel R L, Gershwin ME. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 1988; 141: 2321–2324
   PubMed Web of Science ®Google Scholar
• Coppel R L, NcNeilage L J, Surh C D, Van de Water J, Spithill T W, Whittingham S, Gershwin EM. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Nail Acad Sci 1988; 85: 7317–7321
   PubMed Web of Science ®Google Scholar
• Fussey S PM. Guest JR, James OFW, Bassendine, MF, Yearman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Nail Acad Sci 1988; 85: 8654–8658
   PubMed Web of Science ®Google Scholar
• Yeaman S J, Fussey S PM, Danner D J, James O FW, Mutimer D J, Bassendine MF. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988; 1: 1067–1070
   PubMed Web of Science ®Google Scholar
• Frostell A, Medel-Hartvig I, Nelson BD. Evidence that the major PBC specific mitochondrial autoantigen is a subunit of complex I of the respiratory chain. Scand J Immunol 1988; 28: 157–164
   PubMedGoogle Scholar
• MacKay I R, Gershwin ME. Springer Seminars Immunopath 1990; 12: 101–119, Primary biliary cirrhosis: considerations in the pathogenesis based on identification of the M2 autoantigens
   PubMedGoogle Scholar
• Zanger U M, Hauri H P, Loeper J, Homburg J-C, Meyer UA. Antibodies against human cytochrome P-450dbl in autoimmune hepatitis tye II. Proc Nail Acad Sci 1988; 85: 8256–8260
   PubMed Web of Science ®Google Scholar
• Gueguen M, Meunier-Rotival M, Bernard O, Alvarez F. Antiliver kidney microsome antibody recognize a cytochrome P450 from the IID subfamily. J Exp Med 1988; 163: 801–806
   Google Scholar
• Meier U T, Meyer UA. Genetic polymorphism of human cytochrome P-450 (S)-Mephenytoin 4-Hydroxylase. Biochem. 1987; 26: 8466–8474
   PubMed Web of Science ®Google Scholar
• Manns M P, Johnson E F, Griffin K J, Tan E M, Sullivan KF. Major liver-kidney microsome autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450dbl. J Clin Invest 1989; 83: 1066–1072
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, Camilli P. Identification of the 64k autoantigen in insulin dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–156
   PubMed Web of Science ®Google Scholar
• Karlsson FA. Burman P, Loof L, Mardh S. Major parietal cell antigen in autoimmune gastritis with pernicious anaemia is the acid producing H, K adenosine triphosphatase of the stomach. J Clin Invest 1988; 81: 475–479
   PubMed Web of Science ®Google Scholar
• Furmaniak J, Talbot D, Benker G, Creagh F M, Rees Smith G. Immunoprecipitation of human adrenal microsomal antigen. FEES Letts 1988; 231: 25–28
   PubMedGoogle Scholar
• Bright G M, Singh I. Adrenal autoantibodies bind to adrenal subcellular fractions enriched in cytochrome-C reductase and 5′ -nucleotidase. J Clin Endocrinol Metab 1990; 70: 95–99
   PubMed Web of Science ®Google Scholar
• Tan EM. Chan EKL, Sullivan KF, Rubin RL. Anti-nuclear antibodies. Clin Immunol Immunopath 1988; 47: 121–141
   PubMedGoogle Scholar
• Wraith D C, McDevitt H O, Steinman L, Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell 1989; 57: 709–715
   PubMed Web of Science ®Google Scholar
• Vandenbark A A, Hashim G, Offner H. Immunisation with a synthetic T cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989; 341: 541–544
   PubMed Web of Science ®Google Scholar
• Howell M D, Winters ST. Olee T, Powell HC, Carlo DJ, Brostoff SW. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668–670
   PubMed Web of Science ®Google Scholar
• Harcourt G C, Sommer N, Rothbard J, Willcox N A, Newsom-Davis J. Ajuxtamembrane epitope out he human acetylcholine receptor recognised by T cells in myasthenia gravis. J Clin Invest 1988; 82: 1894–1900
   PubMedGoogle Scholar
• Roep B, Arden S, De Vries R, Hutton J. T cell clones from type l diabetes patient respond to insulin secretory granule proteins. Nature, 345: 632–634
   PubMedGoogle Scholar
• Sanz I, Capra JD. The genetic origin of human autoantibodies. J Immunol 1988; 140: 3283–3285
   PubMedGoogle Scholar
• Rees-Smith B, McLachlan S M, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocrine Revs 1988; 9: 106–121
   PubMed Web of Science ®Google Scholar
• Drachman DB. Myasthenia gravis — biology and treatment. Ann New York Acad Sci 1987; 505
   Google Scholar
• Buyan J P, Ben-Chetrit E, Karp S, Roubey A AS, Pompeo L, Reeves W H, Tan E M, Winchester R. Acquired congenital heart block. J Clin Invest 1989; 84: 627–634
   PubMedGoogle Scholar
• Engel A G, Arahata K. The membrane attack complex of compliment at the endplate in Myasthenia gravis. Ann New York Acad Soc 1987; 505: 326–332
   PubMedGoogle Scholar
• Drachman D B, Adams R N, Jostfek L F, Self SG. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Eng J Med 1982; 307: 769–775
   PubMed Web of Science ®Google Scholar
• Baboonian C, Venables P JW, Booth J, Williams D G, Roffe L M, Maini RN. Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Expt Immunol 1989; 78: 454–459
   PubMed Web of Science ®Google Scholar
• Furukawa F, Kashihara-Sawami M, Lyons M B, Norris DA. Binding of antibodies to the Extractable Nuclear Antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light. J Invest Dermatol 1990; 94: 77–85
   PubMed Web of Science ®Google Scholar
• Kohno Y, Hajama Y, Shimojo N, Niimi H, Nakayama H, Hosoya T. Autoantibodies to thyroid peroxidase in patients with chronic thyroiditis: effect of antibody binding on enzyme activities. Clin Exp Immunol 1986; 65: 534–541
   PubMed Web of Science ®Google Scholar
• Doble N D, Banga J P, Pope R, Lalor, Kilduff P, McGregor AM. Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunol 1988; 64: 23–29
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Hamada N, Saito H, Ohno M, Noh J, Ito K, Morri H. Thyroid peroxidase activity inhibiting immuno-globulins in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1989; 68: 730–734
   PubMedGoogle Scholar
• Yokoyama N, Taurog A, Klee GG. Thyroid peroxidase and thyroid microsomal autoantibodies. J Clin Endocrinol Metab 1989; 68: 766–773
   PubMed Web of Science ®Google Scholar
• Kohno Y, Naito N, Saito K, Hoshioka A, Niimi H, Nakajimia H, Hosoya T. Antithyroid peroxidase antibody activity in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 1989; 75: 217–221
   PubMed Web of Science ®Google Scholar
• Banga J P, Tomlinson R WS, Doble N, Odell E, McGregor AM. Thyroid microsomal/thyroid peroxidase autoantibodies show discrete patterns of cross-reactivity to myeloperoxidase, lactoperoxidase and horseradish peroxidase. Immunol 1989; 67: 197–204
   PubMed Web of Science ®Google Scholar
• Irvin W J, Davies S H, Delamore I W, Williams AW. Immunological relationship between pernicious anaemia and thyroid disease. Er Med J 1962; 2: 454
   Google Scholar
• Schiller K FR, Snyder M, Vallotton MB. Gastric haemato-logical and immunological abnormalities in Hashimoto's thyroiditis. Gut 1967; 8: 582–586
   PubMedGoogle Scholar
• Irvine WJ. Clin Endocrinol Metab 1975; 4: 351–354
   Google Scholar
• De Aizpurva H J, Toh B H, Ungar B. Parietal cell surface reactive autoantibody in pernicious anaemia demonstrated by indirect membrane immunofluoresence. Clin Exp Immunol 1983; 52: 341–349
   PubMedGoogle Scholar
• De Aizpurva H J, Cosgrove L J, Ungar B, Toh BH. Autoantibodies cytotoxic to gastric parietal cells in serum of patients with pernicious aneamia. N Eng J Med 1983; 309: 625–629
   PubMedGoogle Scholar
• Tdnaka N, Glass G BJ. Effect of prolonged administration of parietal cell antibody from patients with atrophic gastritis and pernicious anaemia on the parietal cell mass and hydrochloric acid output in rats. Gastroent 1970; 58: 482–494
   Google Scholar
• Loveridge N, Bitensky L, Choyen J, Hausamen T U, Fisher J M, Taylor K B, Gardner J D, Bottazzo G F, Doniach D. Inhibition of parietal cell function by human gammaglobulin containing gastric parietal cell antibodies. Clin Exp Immunol 1980; 42: 264–270
   Google Scholar
• Mathews M B, Bernstein RM. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 1983; 304: 177–179
   PubMed Web of Science ®Google Scholar
• Rosa M D, Hendrick J P, Lerner M R, Steitz JA. A mammalian tRNA (His) containing antigen is reognised by the polymyositis-specific antibody anti-Jo-I. Nucleic Acids Res 1984; 11: 853–87
   Google Scholar
• Yang D CH, Dang C V, Arnett FC. Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-l autoantibody. Biochem Biophys Res Comm 1984; 120: 15–21
   PubMedGoogle Scholar
• Mathews M B, Reichlin M, Hughes G RV, Bernstein RM. Ant-threonly-tRNA synthetase, as second myositis-related autoantibody. J Exp Med 1984; 160: 420–434
   PubMed Web of Science ®Google Scholar
• Dang C V, Tan E M, Traugh JA. Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase. FASEE J 1988; 2: 2376–2379
   PubMedGoogle Scholar
• Bunn C C, Mathews MB. Autoreactive epitope defined as the anticodon region of alanine transfe RNA. Science 1987; 238: 1116–1119
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Willis E H, Carson DA. Human autoantibodies to poly (Adenosine diphosphate-ribose) polymerase recognise cross-reactive epitopes associated with the catalytic site of the enzyme. J Clin Invest 1989; 83: 180–186
   PubMedGoogle Scholar
• Shero J H, Bordwell B, Rothfield N F, Earnshaw WC. High titers of autoantibodies ot topoisomerase I (Scl-70) in sera from Scleroderma patients. Science 1986; 231: 737–740
   PubMed Web of Science ®Google Scholar
• Chan E KL, Tan EM. Human autoantibody-reative epitopes of SS-B/La are highly conserved in comparison with epitopes recognised by murine monoclonal antibodies. J Exp Med 1987; 166: 1627–1640
   PubMed Web of Science ®Google Scholar
• Reimer G KM, Rose U, Scheer U, Tan EM. Autoantibody to RNA polymerase l in scleroderma sera. J Clin Invest 1987; 79: 65–72
   PubMed Web of Science ®Google Scholar
• Yang V W, Lerner M R, Steitz J A, Flint SJ. A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences. Proc Natl Acad Sci 1981; 78: 1371–1375
   PubMedGoogle Scholar
• Padgett R A, Mount S M, Steitz J A, Sharp PA. Splicing of Messenger RNA precursors is inhibited by antisera to small nuclear ribonucleoprotien. Cell 1983; 35: 101–107
   PubMed Web of Science ®Google Scholar
• Stacey D W, Skelly S, Watson T, Elkon K, Weissbach H, Brot N. The inhibition of protein synthesis by IgG containing anti-ribosome P autoantibodies from systemic lupus erythematosus patients. Arch Biochem Biophys 1988; 267: 398–403
   PubMedGoogle Scholar
• Colman P M, Lever W G, Varghese J N, Baker A T, Tulloch P A, Air G M, Webster RG. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 1987; 326: 358–363
   PubMed Web of Science ®Google Scholar
• Colman P M, Air G M, Webster R G, Varghese J N, Baker A T, Lentz M R, Tulloch P A, Laver WG. How antibodies recognise virus proteins. Immunol Today 1987; 8: 323–326
   PubMedGoogle Scholar
• Banga J P, Barnett P S, Mahadevan D, McGregor AM. Immune recognition of antigen and its relevance to autoimmune disease: recent advances at the molecular level. Eur J Clin Invest 1989; 190: 107–116
   Google Scholar
• De Bruin T W, Patwardhen N A, Brown R S, Braverman LE. Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy. Clin Exp Immunol 1989; 72: 481–485
   Google Scholar